KEGG: sae:NWMN_1849
Recombinant Staphylococcus aureus UPF0316 protein NWMN_1849 is a full-length protein consisting of 200 amino acids derived from Staphylococcus aureus strain Newman. The protein belongs to the UPF0316 family, where "UPF" designates an uncharacterized protein family, indicating that its precise biological function remains to be fully elucidated. For recombinant expression, it is typically fused to an N-terminal His tag and expressed in prokaryotic systems like E. coli . The protein's complete amino acid sequence has been determined, allowing for structural and functional studies to progress despite its uncharacterized status.
The recommended storage protocol for recombinant NWMN_1849 involves specific conditions to maintain protein stability and activity. The protein is typically supplied as a lyophilized powder and should be stored at -20°C/-80°C upon receipt. For long-term storage, aliquoting is necessary to avoid repeated freeze-thaw cycles that can damage protein structure. The recommended storage buffer is Tris/PBS-based with 6% Trehalose at pH 8.0 .
For reconstitution, the protein should be centrifuged briefly before opening to bring contents to the bottom. Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For extended storage of the reconstituted protein, adding glycerol to a final concentration of 5-50% is recommended, with 50% being the default. Working aliquots can be stored at 4°C for up to one week . These precise storage conditions are essential for maintaining protein integrity in experimental workflows.
While E. coli is the most commonly used expression system for NWMN_1849, researchers have several options depending on their experimental requirements:
| Expression System | Advantages | Limitations | Best Applications |
|---|---|---|---|
| E. coli | High yield, rapid growth, cost-effective, well-established protocols | Limited post-translational modifications, potential inclusion body formation | Basic protein characterization, structural studies, antibody production |
| Yeast | Eukaryotic post-translational modifications, high cell density cultivation | Longer expression time than E. coli, different codon usage | Functional studies requiring proper folding or modifications |
| Baculovirus | Advanced eukaryotic processing, high expression levels for complex proteins | Time-consuming, technically demanding, higher cost | Studies requiring authentic eukaryotic modifications |
| Mammalian Cell | Most sophisticated post-translational modifications and folding | Lowest yield, highest cost, longest expression time | Functional studies where native-like protein state is critical |
When choosing an expression system, researchers should consider the downstream applications and the specific requirements for protein folding and modifications . For basic characterization and initial studies, E. coli remains the most efficient system, while more complex functional assays might benefit from alternative expression platforms.
Expression of full-length proteins like NWMN_1849 can present several challenges:
Hydrophobicity issues: Analysis of the NWMN_1849 sequence reveals hydrophobic regions that may impede soluble expression. For proteins with high hydrophobicity, consider using solubility tags (e.g., SUMO, MBP) or specialized E. coli strains designed for membrane protein expression .
Codon optimization: When expressing Staphylococcus aureus proteins in E. coli, codon bias can significantly impact expression efficiency. Codon optimization of the gene sequence for the expression host is recommended to overcome translation bottlenecks caused by rare codons .
Translation initiation problems: Truncated products may result from improper translation initiation or proteolysis. Using fusion tags at both N- and C-termini can help distinguish full-length proteins from truncated versions. Increasing imidazole concentration during purification can also improve specificity when using His-tag affinity chromatography .
Protein toxicity: If NWMN_1849 exhibits toxicity to the expression host, consider using tightly regulated inducible promoters or lower growth temperatures to reduce metabolic burden. Leaky expression can be mitigated by using glucose to suppress basal expression in lac-based systems .
Addressing these challenges requires systematic optimization of expression conditions, including temperature, inducer concentration, and incubation time. Pilot expression studies with small-scale cultures are recommended before scaling up production .
Investigating an uncharacterized protein like NWMN_1849 requires a systematic, multi-faceted approach:
Start with bioinformatic analysis: Begin by comparing NWMN_1849 with characterized proteins using tools like BLAST, Pfam, and structural prediction algorithms. This can provide initial hypotheses about function based on sequence or structural similarities.
Design a sequential experimental plan: Follow a logical progression from basic to complex experiments:
Biochemical characterization (size, oligomeric state, stability)
Structural studies (crystallography, NMR, or cryo-EM)
Functional assays based on bioinformatic predictions
Protein-protein interaction studies
Gene knockout/knockdown studies in S. aureus
Implement proper controls: For each experiment, include both positive and negative controls. For interaction studies, use known interacting proteins as positive controls and unrelated proteins as negative controls .
Consider experimental power: Calculate the required sample size and number of replicates based on anticipated effect size and desired statistical power. This prevents both underpowered studies that miss true effects and wasteful overpowered studies .
Use blocking techniques: When studying protein-protein interactions, use blocking designs to reduce variability and increase precision. This is particularly important when working with complex biological systems where many factors can influence results .
A well-designed experimental approach for NWMN_1849 would incorporate elements from successful studies of other UPF proteins while maintaining flexibility to pursue unexpected findings that may emerge .
When investigating protein-protein interactions involving NWMN_1849, rigorous controls are essential for generating reliable and interpretable data:
Input controls: Always analyze a portion of the initial protein mixture to confirm the presence and quantity of all proteins before interaction assays. This establishes a baseline for comparison .
Tag-only controls: When using tagged versions of NWMN_1849, include the tag alone (e.g., His-tag only) as a control to identify nonspecific interactions caused by the tag rather than NWMN_1849 itself .
Irrelevant protein controls: Include an unrelated protein with similar size and properties to NWMN_1849 to distinguish specific from nonspecific interactions. For example, when testing interactions between NWMN_1849 and potential binding partners, include an unrelated bacterial protein with similar characteristics .
Reciprocal pulldowns: If investigating an interaction between NWMN_1849 and Protein X, perform pulldowns in both directions: using NWMN_1849 as bait to capture Protein X, and using Protein X as bait to capture NWMN_1849. Consistent results from both approaches strengthen evidence for a genuine interaction .
Binding condition variants: Test interactions under different conditions (salt concentration, pH, temperature) to determine the specificity and robustness of the interaction. True interactions often persist across a range of physiologically relevant conditions .
In GST pulldown experiments, for instance, approximately 10% of input UPF proteins typically bind to GST-RF3, providing a benchmark for interaction strength assessment . This type of quantitative evaluation helps distinguish weak but specific interactions from experimental noise.
Studying NWMN_1849 in the context of S. aureus pathogenesis requires careful experimental design considerations:
Selection of appropriate S. aureus strains: Use both laboratory strains and clinical isolates to ensure comprehensive understanding. The Newman strain, from which NWMN_1849 derives, should be compared with other common reference strains (e.g., USA300, MRSA252) to identify strain-specific effects.
Genetic manipulation approaches:
Generate clean deletion mutants of NWMN_1849 using allelic replacement
Create complemented strains to verify phenotypes
Consider conditional expression systems for essential genes
Implement CRISPR-Cas9 systems for precise genetic manipulation
Phenotypic characterization pipeline:
| Phenotypic Aspect | Methodological Approach | Key Controls | Expected Outcomes |
|---|---|---|---|
| Growth kinetics | Growth curves in various media and stress conditions | Wild-type strain, unrelated mutant strain | Changes in growth rate or lag phase |
| Biofilm formation | Crystal violet staining, confocal microscopy | Known biofilm regulators (positive/negative) | Altered biofilm architecture or density |
| Virulence factor expression | qRT-PCR, Western blotting, activity assays | Housekeeping gene controls, purified proteins | Changes in expression patterns or activity |
| Host-cell interactions | Infection of relevant cell lines, cytotoxicity assays | Known virulence factor mutants | Altered adhesion, invasion, or cytotoxicity |
| In vivo virulence | Animal infection models | Wild-type infection, mock infection | Changes in bacterial burden, tissue damage, or survival |
Avoiding experimental bias: Implement randomization in animal studies and blinding in assessment of outcomes. Use blocking designs to account for variability in experimental conditions .
Protocol optimization: For each assay, conduct pilot experiments to determine optimal conditions. For infection models, carefully define endpoints and sample size based on expected effect sizes .
This systematic approach enables robust assessment of NWMN_1849's role in pathogenesis while minimizing experimental artifacts and maximizing reproducibility .
While specific information about NWMN_1849's relationship to other UPF proteins is limited in the search results, insights can be drawn from general UPF protein research:
A methodological approach to explore NWMN_1849's relationships with other UPF proteins would include:
Phylogenetic analysis: Construct phylogenetic trees of UPF0316 family proteins across bacterial species to identify evolutionary relationships and conserved domains. This can provide insights into potential shared functions.
Structural comparisons: Use techniques like X-ray crystallography or structural prediction tools to compare NWMN_1849's three-dimensional structure with other UPF proteins. Structural similarities often suggest functional similarities even when sequence homology is limited.
Functional complementation studies: Express NWMN_1849 in bacterial systems lacking related UPF proteins to assess whether it can complement their functions. This approach has been successful in characterizing relationships between UPF3A and UPF3B in eukaryotic systems .
Protein-protein interaction network analysis: Identify interaction partners of NWMN_1849 and compare them with known interactors of other UPF proteins to map functional relationships. For example, studies of eukaryotic UPF proteins revealed interactions with release factors (RFs) that provide clues to their functions .
Understanding these relationships could provide valuable insights into bacterial RNA processing and quality control mechanisms, potentially revealing novel targets for antimicrobial development.
Post-translational modifications (PTMs) can significantly impact protein function and activity. For NWMN_1849, a systematic approach to PTM analysis would include:
Prediction-based screening: Begin with computational prediction of potential PTM sites using algorithms specific for bacterial proteins. Common bacterial PTMs include phosphorylation, methylation, acetylation, and glycosylation.
Mass spectrometry-based identification:
Use high-resolution LC-MS/MS for unbiased PTM discovery
Implement enrichment strategies for specific PTMs (e.g., phosphopeptide enrichment using TiO₂)
Compare PTM profiles under different growth conditions to identify regulated modifications
Site-specific validation: Once potential PTM sites are identified, validate them using:
Site-directed mutagenesis to create non-modifiable variants
PTM-specific antibodies (when available)
Functional assays comparing wild-type and mutant proteins
Quantitative PTM analysis: For studying dynamics of modifications:
| Technique | Application | Advantages | Limitations |
|---|---|---|---|
| SILAC | Comparing PTMs between conditions | High accuracy, compatible with most MS workflows | Requires metabolic labeling, limited to culture systems |
| TMT/iTRAQ | Multiplexed PTM quantification | Can compare multiple conditions in one run | Chemical labeling can be incomplete, reporter ion interference |
| Label-free quantification | Flexible PTM profiling | No labeling required, unlimited sample types | Lower precision than labeling methods |
| Parallel reaction monitoring | Targeted PTM quantification | High sensitivity for specific sites | Requires prior knowledge of sites of interest |
Functional impact assessment: For each validated PTM, assess its impact on:
Protein stability and half-life
Subcellular localization
Protein-protein interactions
Enzymatic activity (if applicable)
This comprehensive approach would provide insights into how NWMN_1849's function might be regulated post-translationally in different environmental contexts, potentially revealing mechanisms of adaptation or virulence regulation in S. aureus.
When faced with contradictory results in NWMN_1849 research, a systematic approach to resolution includes:
Examine methodological differences: Carefully compare experimental protocols, including:
Protein preparation methods (tags, purification approach)
Assay conditions (buffer composition, temperature, pH)
Detection methods and their sensitivity
Statistical approaches and significance thresholds
Consider biological context: Different experimental systems might reveal different facets of protein function:
In vitro vs. in vivo studies
Heterologous expression vs. native context
Different bacterial strains or growth conditions
Acute vs. chronic infection models
Evaluate experimental design quality: Assess whether contradictions might stem from design limitations :
Sample size and statistical power
Appropriate controls
Blinding and randomization
Potential confounding variables
Implement reconciliation experiments: Design studies specifically to address contradictions:
Side-by-side comparisons under standardized conditions
Dose-response or time-course experiments that might reveal threshold effects
Combination approaches that test multiple variables simultaneously
Apply Bayesian thinking: Update confidence in hypotheses based on the strength and reproducibility of evidence rather than binary acceptance/rejection of findings .
When reanalyzing experimental results, consider that slight modifications to conditions can significantly impact outcomes. For example, protein interaction studies might benefit from adjusting selection strength: "simulations predict that both experiments would have benefited from slightly weaker selection... which would have enabled a faster exploration of the neighborhood of the wildtype sequence and the occurrence of slightly more deleterious mutations" .
Given NWMN_1849's uncharacterized status, bioinformatics approaches offer valuable starting points for functional prediction:
Sequence-based analysis:
Multiple sequence alignment with homologs to identify conserved residues
Motif scanning to detect functional domains
Transmembrane topology prediction (particularly relevant given the sequence characteristics of NWMN_1849 suggesting membrane association)
Signal peptide and subcellular localization prediction
Structure-based prediction:
Ab initio structure prediction using AlphaFold2 or RoseTTAFold
Template-based modeling using solved structures of related proteins
Structural alignment with functionally characterized proteins
Active site and binding pocket identification
Genomic context analysis:
Examination of genomic neighborhood for functionally related genes
Operon structure prediction
Comparative genomics across Staphylococcus species
Co-expression pattern analysis
Integrated approaches:
| Approach | Tools | Strengths | Limitations |
|---|---|---|---|
| Protein-protein interaction prediction | STRING, STITCH | Provides functional context | High false positive rate |
| Evolutionary coupling analysis | EVcouplings, RaptorX | Can detect functional residues | Requires large sequence families |
| Gene ontology prediction | DeepGOPlus, FFPred | Provides standardized function terms | Limited by training data |
| Literature mining | PubTator, EVEX | Integrates published knowledge | Limited by publication bias |
Validation planning: Design experiments to test predictions using:
Site-directed mutagenesis of predicted functional residues
Domain deletion/swapping to test functional assignments
Heterologous expression to test predicted activities
While computational predictions provide valuable hypotheses, experimental validation remains essential. As noted in recent protein structure prediction research: "our computational approach is very efficient and can be applied to thousands of protein families, while the experiments are very expensive in time and resources. Guiding them to increase the success probability may therefore be an impactful strategy" .
Validating computational predictions about NWMN_1849 requires a strategic experimental approach:
Prioritize predictions based on confidence scores and biological relevance:
Focus on predictions with high confidence scores from multiple tools
Prioritize predictions relevant to S. aureus biology and pathogenesis
Consider the experimental feasibility of validation
Design a multi-level validation strategy:
| Prediction Type | Validation Approach | Critical Controls | Success Metrics |
|---|---|---|---|
| Protein-protein interactions | Co-immunoprecipitation, GST pulldown, Y2H | Non-interacting proteins, tag-only controls | Reciprocal confirmation, concentration-dependent binding |
| Enzymatic activity | Biochemical assays specific to predicted function | Heat-inactivated protein, active site mutants | Kinetic parameters, substrate specificity |
| Membrane localization | Fractionation, GFP fusion imaging | Cytoplasmic/membrane marker proteins | Co-localization coefficients, enrichment factors |
| Structural features | CD spectroscopy, limited proteolysis | Denatured protein, structure-disrupting conditions | Concordance with predicted secondary structure |
Implement targeted mutagenesis:
Create alanine substitutions of predicted critical residues
Design domain deletion constructs to test modular function
Generate chimeric proteins to test domain function predictions
Apply orthogonal approaches:
Use multiple independent techniques to test each prediction
Combine in vitro, in vivo, and in silico approaches
Implement genetic and biochemical methods in parallel
Establish quantitative success criteria before experimentation:
Define thresholds for accepting/rejecting predictions
Establish statistical requirements (p-values, confidence intervals)
Determine required replication levels based on expected effect sizes
Iterative refinement:
Use initial results to refine computational models
Develop second-generation predictions incorporating experimental data
Create a feedback loop between computation and experimentation
This approach maximizes the efficiency of validation efforts while maintaining scientific rigor. As noted in experimental design literature: "our approach can be used to explore different protocols, such as alternating cycles of strong and weak selection" , suggesting that adaptive experimental strategies are particularly valuable for novel protein characterization.
While direct evidence of NWMN_1849's role in pathogenesis is not explicitly stated in the search results, its investigation as a potential pathogenesis factor is warranted based on several considerations:
Membrane protein characteristics: Analysis of NWMN_1849's amino acid sequence reveals features consistent with a membrane protein, including hydrophobic segments that may form transmembrane domains . Bacterial membrane proteins often play crucial roles in:
Adhesion to host surfaces
Nutrient acquisition in the host environment
Evasion of host immune responses
Antibiotic resistance mechanisms
Research focus on recombinant production: The emphasis on recombinant production of NWMN_1849 for vaccine development suggests potential immunogenicity and relevance to host-pathogen interactions .
Methodological approach to investigate pathogenesis roles:
a) Gene expression analysis: Measure NWMN_1849 expression under conditions mimicking host environments (serum exposure, phagocytosis, biofilm formation) to identify potential regulation patterns associated with virulence.
b) Mutagenesis studies: Create and characterize NWMN_1849 deletion and complemented strains in:
Growth assays under various stresses
Biofilm formation models
Host cell adhesion and invasion assays
Animal infection models
c) Antimicrobial susceptibility testing: Compare minimum inhibitory concentrations (MICs) of various antibiotics between wild-type and NWMN_1849-mutant strains to identify potential contributions to resistance.
d) Interaction with host factors: Investigate potential interactions between NWMN_1849 and host immune components or extracellular matrix proteins using techniques such as far-Western blotting or surface plasmon resonance.
Given S. aureus' clinical importance and the challenges of antimicrobial resistance, characterizing proteins like NWMN_1849 may reveal novel therapeutic targets or vaccine candidates. The investigation should follow rigorous experimental design principles to ensure reliable and reproducible results .
NWMN_1849 can serve as a valuable component in functional genomics studies aiming to comprehensively understand S. aureus biology:
Integration into genomic interaction networks:
Perform systematic genetic interaction screens (e.g., synthetic genetic array) with NWMN_1849 deletion to identify genetic relationships
Map physical interaction networks using techniques like affinity purification-mass spectrometry
Integrate NWMN_1849 into existing S. aureus gene-gene and protein-protein interaction networks
Transcriptomic analysis approaches:
Compare RNA-seq profiles between wild-type and NWMN_1849 mutant strains under various conditions
Identify co-expressed genes through correlation network analysis
Use conditional expression systems to perform time-resolved expression studies
Integrated multi-omics studies:
| Omics Level | Technique | Application to NWMN_1849 | Integration Approach |
|---|---|---|---|
| Genomics | Whole genome sequencing | Identify strain variation in NWMN_1849 | Correlate sequence variants with phenotypes |
| Transcriptomics | RNA-seq, microarray | Determine expression patterns and regulons | Connect expression to regulatory networks |
| Proteomics | MS-based proteomics | Quantify protein levels and interactions | Map to transcriptional changes |
| Metabolomics | LC-MS, NMR | Identify metabolic changes in mutants | Link metabolic shifts to protein function |
| Phenomics | High-throughput phenotyping | Characterize mutant traits under multiple conditions | Connect molecular changes to phenotypes |
CRISPR-based functional genomics:
Implement CRISPRi for partial knockdown to assess dosage effects
Use CRISPR activation to study the effects of NWMN_1849 overexpression
Employ multiplexed CRISPR screens to identify synthetic interactions
Comparative genomics across S. aureus strains:
Compare NWMN_1849 sequence, genomic context, and expression across clinical isolates
Correlate variations with strain-specific phenotypes (virulence, antibiotic resistance)
Identify selective pressures through evolutionary analysis
This multi-faceted approach allows researchers to place NWMN_1849 within the broader context of S. aureus biology, providing insights into both its specific functions and its contributions to bacterial physiology and pathogenesis. As noted in experimental design literature, such comprehensive approaches benefit from careful planning to "optimize experimental design" and "guide experiments to increase the success probability" .
The most promising research directions for elucidating NWMN_1849 function combine cutting-edge technologies with classical approaches:
Structural biology approaches:
High-resolution structure determination via X-ray crystallography or cryo-EM
Molecular dynamics simulations to understand conformational changes
Ligand binding site identification and characterization
Systems biology integration:
Network analysis to position NWMN_1849 within S. aureus cellular pathways
Multi-omics data integration to understand contextual function
Mathematical modeling of NWMN_1849's role in cellular processes
Translational applications:
Assessment as a potential diagnostic biomarker for S. aureus infections
Evaluation as a vaccine candidate or therapeutic target
Development of structure-based inhibitors if enzymatic activity is identified
Evolutionary perspectives:
Comparative analysis across bacterial species to understand conservation
Investigation of selective pressures shaping NWMN_1849 evolution
Horizontal gene transfer assessment in the context of pathogen evolution
Novel methodology application:
Single-molecule techniques to study dynamic interactions
Live-cell imaging to track protein localization and dynamics
High-throughput mutagenesis approaches like deep mutational scanning
As with all scientific endeavors, these approaches should be pursued with careful experimental design that incorporates appropriate controls, statistical power considerations, and replication . The uncharacterized nature of NWMN_1849 presents both challenges and opportunities, making it an excellent candidate for innovative research approaches that could yield insights into fundamental aspects of S. aureus biology.
Research on NWMN_1849 has the potential to advance understanding of the entire UPF0316 protein family through several strategic approaches:
Establish NWMN_1849 as a model protein:
Develop a comprehensive toolkit for NWMN_1849 study (antibodies, expression constructs, purification protocols)
Create a standardized set of assays for functional characterization
Share resources openly with the research community to facilitate comparative studies
Perform comparative studies across UPF0316 family members:
Extend findings from NWMN_1849 to homologs in other bacterial species
Identify conserved and divergent functional features
Test functional complementation between family members
Establish a systematic classification framework:
Develop a functional classification system for UPF0316 proteins
Map sequence variations to functional differences
Create predictive models for function based on sequence features
Contribute to community resources:
Deposit structures and functional data in public databases
Develop specialized databases or knowledge bases for UPF0316 proteins
Participate in community annotation projects
Apply consistent methodological approaches:
Develop standardized protocols for UPF0316 protein characterization
Use consistent reporting formats to facilitate meta-analyses
Implement rigorous experimental design principles to ensure reproducibility
The systematic characterization of NWMN_1849 could serve as a template for studies of other uncharacterized protein families, potentially accelerating functional annotation across bacterial proteomes. This would contribute significantly to closing the gap between sequence data accumulation and functional characterization in the era of high-throughput genomics.